Wistar Scientists Identify Key Biomarkers that Reliably Predict Response to Immune Checkpoint Inhibitor Therapy for Melanoma 

Currently, the only FDA approved biomarker for ICI melanoma treatment is the tumor mutation burden assay, but the mechanisms linking it to ICI remain unclear. However, new research out of The Wistar Institute now provides evidence of novel, reliable biomarkers that predict therapy response using advanced computer technology.

MD Anderson Research Highlights: ESMO 2022 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features upcoming oral presentations by MD Anderson researchers at the European Society for Medical Oncology (ESMO) Congress 2022 focused on clinical advances across a variety of cancer types. Highlights include promising early data from a novel T cell therapy for solid tumors, targeted therapy progress in rare and advanced cancers, biomarkers of immunotherapy response, and features associated with clinical outcomes in leptomeningeal disease. More information on ESMO content from MD Anderson can be found at MDAnderson.org/ESMO.

6 skin biopsy wound care tips from dermatologists

Skin cancer is the most common form of cancer. It is estimated that one in five Americans will develop skin cancer in their lifetime. As Skin Cancer Awareness Month continues, it’s important to check your skin regularly, and if you notice a spot on your skin that is different from others or that changes, itches, or bleeds, make an appointment to see a board-certified dermatologist.

‘Honey, don’t forget the sunscreen!’ Three beliefs that affect sunscreen use by older adults

Reminders from a romantic partner might be an effective way to encourage sunscreen use by people age 50 or older, suggests a study in the May/June issue of The Journal of the Dermatology Nurses’ Association, official publication of the Dermatology Nurses’ Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.

New survey reveals most Americans say sun protection is more important now than five years ago, yet many misunderstand how to protect themselves

In a recent survey of more than 1,000 U.S. adults, the American Academy of Dermatology found that while respondents gave themselves high ratings for sun protection and most reported that sun protection is more important to them now than it was five years ago, there’s still a lot they don’t know about how to protect themselves from the sun and the risks of sun exposure, including skin cancer —the most common cancer in the U.S.

Filling in the Gaps

With all that the Land of Enchantment has to offer, skin cancer isn’t on the top on anyone’s list. But abundant sunshine and a dearth of dermatologists in the state pose a challenge for detecting and treating the various forms of skin cancer. Skin Cancer Screening clinics are now resuming. The first of several new clinics will be held in Albuquerque on Saturday, May 7. More are planned over the coming year in Gallup, Taos and southern New Mexico.

National Healthy Skin Month: Dermatologists encourage regular skin checks

The American Academy of Dermatology highlights the importance of regular skin self-exams during National Healthy Skin Month this November. These exams help catch serious conditions early when they are most treatable. Research shows nearly one in four Americans have skin disease. Skin cancer remains the most common cancer in the United States with an estimated 9,500 people diagnosed every day.

New AAD survey: Only a third of Americans are concerned about skin cancer despite nearly 70% having at least one risk factor

With the first day of summer right around the corner, many Americans will increasingly head to the beach or water parks to cool down, but will they turn up their efforts to protect their skin from the sun? A new American Academy of Dermatology survey shows that despite skin cancer being the most common cancer in the U.S., only about one-third of adults are concerned about developing the disease, even though nearly 70% say they have at least one risk factor for skin cancer.

Health, safety tips for summer activities: IU experts available to comment

As Memorial Day weekend approaches, many people have plans to enjoy outdoor activities in the warmer weather. And while we have vaccines to protect against COVID-19, there are other safety measures to keep in mind while having fun in the…

Skin cancer expert available during Melanoma Awareness Month and as summer approaches

As summer approaches and outdoor activities increase, cancer expert William Wooden, M.D., reminds everyone to practice sun safety to protect against skin cancer. Wooden specializes in melanoma research at Indiana University Melvin and Bren Simon Comprehensive Cancer Center and is…

How to Check Your Nails for Melanoma

When checking the body for signs of skin cancer, many people may only think to check their skin. However, board-certified dermatologists from the American Academy of Dermatology say it’s important to check the nails, too. Although rare, skin cancer, including melanoma — the deadliest form of skin cancer — can develop under and around the fingernails and toenails.

TELL “SKIN CANCER, TAKE A HIKE!™” DURING STEPS CHALLENGE FOR SKIN CANCER AWARNESS MONTH

Skin cancer is the most common cancer in the United States, affecting one in five Americans during their lifetime. To help raise awareness of skin cancer prevention and detection, the American Academy of Dermatology will host Skin Cancer, Take a Hike!™, a month-long steps challenge, beginning Sat., May 1 in recognition of Skin Cancer Awareness Month. The participant-driven fundraising event — part of the AAD’s SPOT Skin Cancer™ campaign to create a world without skin cancer — aims to log 9,500 miles across the country in honor of the approximately 9,500 people who are diagnosed with skin cancer every day.

Tanning Beds and Skin Cancer: Heeding the Call to Action

Public health officials and researchers have become increasingly concerned about the health risks posed by indoor tanning. Researchers at Rutgers Cancer Institute of New Jersey recently addressed the importance of increasing efforts to limit indoor tanning among minors in a viewpoint paper published in the April 28 2021 online edition of JAMA Dermatology.

How the Pandemic Has Exacerbated Rates of Skin Cancer

With summer approaching and more and more people getting vaccinated for COVID-19, many San Diegans eagerly anticipate the season best known for outdoor activities. But with more time in the sun comes the need for sun-safe practices. During the pandemic,…

$10 Million Gift to Open the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai

With highly trained specialists skilled in caring for different types of melanoma, patients at the Waldman Melanoma and Skin Center will have access to the newest diagnostics and therapies such as Canfield Vectra180 – a 3D whole body imaging system that captures nearly the entire skin surface in macro quality resolution, and will be able to capture early skin cancer lesions; Nevisense—a safe diagnostic support tool utilizing Electrical Impedence Spectroscopy (EIS) which is applied as a harmless electrical signal to the skin; Vivascope 1500—a non-invasive confocal imaging system which offers a non-invasive way to image the skin to the superficial collagen layers; and innovative technologies which non-invasively collects skin cells through adhesive patches rather than a scalpel to diagnose atypical pigmented lesions (or moles) at high risk for melanoma.

NYU Medical Center Board-Certified Dermatologist: How COVID-19 Caused Delays in Skin Cancer Diagnosis

NYU Medical Center Board-Certified Dermatologist: How COVID-19 Caused Delays in Skin Cancer Diagnosis When caught early, skin cancer, including melanoma — the deadliest form of skin cancer — is highly treatable. However, from March to May 2020 during the peak…

Weizmann Institute of Science and Colleagues Show How Cancer Cells Hurt Themselves to Hurt Immune Cells More

Melanoma is skilled at evading therapies, with its cells going so far as to starve in order to stop the immune cells that would eradicate them. A team from the Weizmann Institute, including Prof. Yardena Samuels; the Netherlands Cancer Institute; and the University of Oslo have revealed one of melanoma’s tricks – never before seen in human cells – and a therapeutic target.

Plastic Surgeon Matthew S. Coons, M.D., FACS Joins Hackensack Meridian Mountainside Medical Group

Mountainside Medical Group announced today that plastic surgeon Matthew S. Coons, M.D., FACS, has joined the practice.

Dr. Coons is board certified by the American Board of Surgery and the American Board of Plastic Surgery. His interests also include hand surgery and reconstructive surgery with an emphasis on breast reconstruction.

FAU Offers New ‘Dermatology Nurse Practitioner Post-graduate Certificate Program’

The nation faces physician shortages in primary care and other specialties, including a projected inadequate supply of dermatologists to meet the demand for service. This innovative program will help to address these gaps and will equip advanced-practice nurses with the tools required to provide high-quality, holistic care for their patients with dermatological conditions.

Doctors motivated by both health, malpractice concerns when ordering additional tests

A UCLA-led study has found that dermatopathologists, who specialize in diagnosing skin diseases at the microscopic level, are motivated both by patient safety concerns and by malpractice fears — often simultaneously — when ordering multiple tests and obtaining second opinions, with a higher proportion of these doctors reporting patient safety as a concern.
When ordering additional microscopic tests for patients, 90% of the dermatopathologists surveyed cited patient safety as a concern and 71% of them reported malpractice fears. Similarly, when obtaining second reviews from a consulting pathologist or recommending additional surgical sampling, 91% cited safety concerns and 78% malpractice concerns.